Int J Clin Pediatr

International Journal of Clinical Pediatrics, ISSN 1927-1255 print, 1927-1263 online, Open Access

Article copyright, the authors; Journal compilation copyright, Int J Clin Pediatr and Elmer Press Inc

Journal website http://www.theijcp.org

Original Article

Volume 1, Number 1, February 2012, pages 25-29

Serum Immunoglobulin Values and Lymphocytes' Phenotypes, in Children Undergoing Adneotonsillectomy

**Table 1.** Mean and Standard Deviation of Serum Values of Immunoglobulins in Our Children
	Case	Control	P-value
IgM	Prior operation	1.52	1.33	1.26	1.23	0.35
	Post operation (two months)	1.76	2.09	1.56	1.89	0.64
	Post operation (six months)	1.62	2.17	1.45	2.25	0.73
IgA	Prior operation	1.37	0.78	1.44	1.02	0.75
	Post operation (two months)	1.27	0.71	1.32	0.89	0.79
	Post operation (six months)	1.23	0.61	1.29	0.79	0.72
IgG	Prior operation	10.37	2.87	10.15	2.65	0.72
	Post operation (two months)	10.52	2.16	10.44	2.12	0.87
	Post operation (six months)	11.05	2.50	10.89	1.45	0.68
IgG1	Prior operation	40.51	19.34	41.44	19.38	0.83
	Post operation (two months)	40.02	17.11	42.11	18.12	0.60
	Post operation (six months)	46.29	16.11	47.32	17.12	0.77
IgG2	Prior operation	100.66	37.08	99.86	35.46	0.92
	Post operation (two months)	105.26	41.13	103.23	39.12	0.83
	Post operation (six months)	101.59	30.84	99.87	29.47	0.80
IgG3	Prior operation	25.80	9.90	26.34	10.12	0.81
	Post operation (two months)	22.29	10.56	24.32	11.65	0.43
	Post operation (six months)	22.80	8.79	23.78	9.67	0.65
IgG4	Prior operation	21.67	16.13	22.87	17.25	0.18
	Post operation (two months)	23.92	19.24	24.89	21.34	0.84
	Post operation (six months)	22.66	16.50	23.76	17.04	0.77

Table 1. Mean and Standard Deviation of Serum Values of Immunoglobulins in Our Children

Case

Control

P-value

Mean

IgM

Prior operation

1.52

1.33

1.26

1.23

0.35

Post operation (two months)

1.76

2.09

1.56

1.89

0.64

Post operation (six months)

1.62

2.17

1.45

2.25

0.73

IgA

Prior operation

1.37

0.78

1.44

1.02

0.75

Post operation (two months)

1.27

0.71

1.32

0.89

0.79

Post operation (six months)

1.23

0.61

1.29

0.79

0.72

IgG

Prior operation

10.37

2.87

10.15

2.65

0.72

Post operation (two months)

10.52

2.16

10.44

2.12

0.87

Post operation (six months)

11.05

2.50

10.89

1.45

0.68

IgG1

Prior operation

40.51

19.34

41.44

19.38

0.83

Post operation (two months)

40.02

17.11

42.11

18.12

0.60

Post operation (six months)

46.29

16.11

47.32

17.12

0.77

IgG2

Prior operation

100.66

37.08

99.86

35.46

0.92

Post operation (two months)

105.26

41.13

103.23

39.12

0.83

Post operation (six months)

101.59

30.84

99.87

29.47

0.80

IgG3

Prior operation

25.80

9.90

26.34

10.12

0.81

Post operation (two months)

22.29

10.56

24.32

11.65

0.43

Post operation (six months)

22.80

8.79

23.78

9.67

0.65

IgG4

Prior operation

21.67

16.13

22.87

17.25

0.18

Post operation (two months)

23.92

19.24

24.89

21.34

0.84

Post operation (six months)

22.66

16.50

23.76

17.04

0.77

**Table 2.** Comparison of Lymphocyte Phenotypes in Our Study Samples and Control Group
Lymphocyte markers	Case group	Control group	Significances
CD2	Prior operation	74.54	4.47	75.15	5.27	0.60
	Post infection (2 months)	75.66	5.06	74.46	4.08	0.21
	Post infection (6 months)	69.79	14.01	71.54	12.46	0.54
CD3	Prior operation	62.17	7.90	63.26	8.11	0.55
	Post infection (2 months)	63.90	6.60	64.36	7.44	0.78
	Post infection (6 months)	59.66	10.43	57.78	9.86	0.43
CD4	Prior operation	33.07	7.39	36.18	5.32	0.02
	Post infection (2 months)	35.40	11.03	36.18	5.32	0.61
	Post infection (6 months)	32.88	12.51	36.18	5.32	0.05
CD8	Prior operation	28.90	6.31	25.85	4.76	0.00
	Post infection (2 months)	28.31	6.08	25.85	4.76	0.03
	Post infection (6 months)	24.28	4.76	25.85	4.76	0.15
CD4/CD8	Prior operation	1.25	0.50	1.41	1.15	0.51
	Post infection (2 months)	1.36	0.64	1.41	1.15	0.83
	Post infection (6 months)	1.43	0.64	1.41	1.15	0.93
CD19	Prior operation	15.47	5.17	18.42	5.4	0.02
	Post infection (2 months)	13.70	3.61	18.42	5.4	0.00
	Post infection (6 months)	13.93	3.59	18.42	5.4	0.00
CD23	Prior operation	4.63	3.02	4.54	2.12	0.86
	Post infection (2 months)	6.03	2.48	5.89	2.45	0.80
	Post infection (6 months)	7.18	3.09	6.35	4.08	0.34
CD56	Prior operation	9.80	6.21	9.39	4.69	0.71
	Post infection (2 months)	10.05	5.63	9.39	4.69	0.55
	Post infection (6 months)	3.30	2.34	9.39	4.69	0.00

Table 2. Comparison of Lymphocyte Phenotypes in Our Study Samples and Control Group

Lymphocyte markers

Case group

Control group

Significances

Mean

CD2

Prior operation

74.54

4.47

75.15

5.27

0.60

Post infection (2 months)

75.66

5.06

74.46

4.08

0.21

Post infection (6 months)

69.79

14.01

71.54

12.46

0.54

CD3

Prior operation

62.17

7.90

63.26

8.11

0.55

Post infection (2 months)

63.90

6.60

64.36

7.44

0.78

Post infection (6 months)

59.66

10.43

57.78

9.86

0.43

CD4

Prior operation

33.07

7.39

36.18

5.32

0.02

Post infection (2 months)

35.40

11.03

36.18

5.32

0.61

Post infection (6 months)

32.88

12.51

36.18

5.32

0.05

CD8

Prior operation

28.90

6.31

25.85

4.76

0.00

Post infection (2 months)

28.31

6.08

25.85

4.76

0.03

Post infection (6 months)

24.28

4.76

25.85

4.76

0.15

CD4/CD8

Prior operation

1.25

0.50

1.41

1.15

0.51

Post infection (2 months)

1.36

0.64

1.41

1.15

0.83

Post infection (6 months)

1.43

0.64

1.41

1.15

0.93

CD19

Prior operation

15.47

5.17

18.42

5.4

0.02

Post infection (2 months)

13.70

3.61

18.42

5.4

0.00

Post infection (6 months)

13.93

3.59

18.42

5.4

0.00

CD23

Prior operation

4.63

3.02

4.54

2.12

0.86

Post infection (2 months)

6.03

2.48

5.89

2.45

0.80

Post infection (6 months)

7.18

3.09

6.35

4.08

0.34

CD56

Prior operation

9.80

6.21

9.39

4.69

0.71

Post infection (2 months)

10.05

5.63

9.39

4.69

0.55

Post infection (6 months)

3.30

2.34

9.39

4.69

0.00